Back to top
Trauma patients find relief from a treatment with cannabis according to a survey
by IACM on 26/09/17

Patients with musculoskeletal trauma profit from a treatment with cannabis according to survey data. Harvard Medical School investigators asked 500 patients at two trauma centres. The majority of patients felt that cannabis could be used to treat pain (78%) and anxiety (62%). Most patients (60%) had used cannabis at least once previously, while only 14% reported using cannabis following their injury.

Of those who used cannabis during their recovery, 90% (63 of 70) said that it reduced...

Cannabis may be effective in the treatment of chronic pain according to a large case series from Italy
by IACM on 14/06/17

A group of researchers from the University of Parma, University of Naples “Federico II”, and other Italian institutions presented a retrospective case series analysis of all chronic pain patients treated with oral or vaporized cannabis in six centers during the initial year following the approval of the new Italian law (December 2015 to November 2016). They evaluated routes of administration, types of cannabis products utilized, dosing, and effectiveness and safety of the treatment.

...

El cannabidiol es eficaz en la epilepsia causada por el síndrome de Dravet
by IACM on 08/06/17

New England Journal of Medicine acaba de publicar un estudio clínico realizado con 120 niños y adultos jóvenes con síndrome de Dravet, que muestra que el CBD (cannabidiol) es eficaz en el control de los síntomas. En el ensayo, controlado con placebo y de 14 semanas de duración, participaron varias instituciones de Estados Unidos.

La frecuencia media de convulsiones por mes disminuyó de 12’4 a 5’9 con CBD, en comparación con la disminución de 14’9 a 14’1 con placebo. El porcentaje de...

Según una gran encuesta el cannabis se utiliza como sustituto de medicamentos recetados
by IACM on 01/06/17

Según una encuesta on-line en el que participaron 2774 individuos que informaron haber consumido cannabis al menos una vez en los 90 días anteriores, aproximadamente la mitad dijo que lo hacían como sustituto de medicamentos recetados. Este es el resultado de la investigación realizada por científicos del Centro para la Educación Médica del Cannabis de Del Mar, el Instituto de Investigación de la Universidad de Bastyr de Kenmore y el Departamento de Investigación Médica del Centro de...

Cannabis is used as a substitute for prescription drugs according to a large survey
by IACM on 01/06/17

According to an online survey with 2774 participants, who reported having used cannabis at least once in the previous 90 days about a half said that they used cannabis as a substitute for prescription drugs. This is the result of research by scientists of the Center for Medical Cannabis Education in Del Mar, Bastyr University Research Institute in Kenmore and the Department of Medical Research, Center for the Study of Cannabis and Social Policy in Seattle, USA.

A total of 1,248 (46%)...

Bajas dosis de THC restauran la función cognitiva en ratones viejos
by IACM on 24/05/17

En un estudio llevado a cabo con ratones de 12 y 18 meses, dosis bajas de THC invirtieron la disminución del rendimiento cognitivo relacionado con la edad. Estos resultados fueron presentados por científicos de la Universidad de Bonn, Alemania, y de la Universidad Hebrea de Jerusalén, Israel. En general los ratones muestran deficiencias cognitivas a la edad de 12 meses. Los ratones recibieron THC durante cuatro semanas.

El tratamiento con THC restauró los patrones de transcripción...

Depression is higher in pain patients receiving opioids compared to those receiving cannabis
by IACM on 18/05/17

In a study with 880 chronic pain patients treated at several centres in Israel those, who received prescription opioids had higher rates of depression and anxiety than those treated with cannabis. Of all participants 474 received opioids, 329 cannabis and 77 both opioids and cannabis. Depression and anxiety were assessed using the depression module of the Patient Health Questionnaire and the Generalized Anxiety Disorder scale.

Prevalence of depression among patients in the opioid...

Los pacientes que consumen cannabis reducen la ingesta de medicamentos para el dolor, la ansiedad, la migraña y los trastornos del sueño
by IACM on 18/04/17

In an online survey of 1,513 patients, who receive cannabis from dispensaries, researchers from different scientific institutions across the USA revealed that a large number significantly reduced their use of several other medications.

Among respondents that regularly used opioids, over three-quarters (76.7%) indicated that they reduced their use since they started the medical use of cannabis. Approximately two-thirds of patients decreased their use of anti-anxiety drugs (71.8%),...

Israel: The government wants to decriminalize small-scale recreational cannabis use
by IACM on 15/02/17

Israel plans to decriminalize cannabis use, Internal Security Minister Gilad Erdan said on 26 January. He said that if the government approves his new policy, those caught smoking cannabis would be punished by a fine rather than arrested and prosecuted. Criminal procedures would be launched only against those caught repeatedly.

“Police will be able to redirect resources … away from normative personal users and focus instead on dangerous drugs,” Erdan told a news conference in Tel Aviv...

EEUU: Nuevo informe de la Academia Nacional de Ciencias sobre el cannabis
by IACM on 15/02/17

En 1999 el Instituto de Medicina de la Academia Nacional de Ciencias de los Estados Unidos publicó un informe sobre los efectos de la marihuana sobre la salud. Ahora la Academia ha publicado una actualización. El nuevo informe dice que la ciencia médica actual ha demostrado que hay usos médicos legítimos para la marihuana y los fármacos derivados del cannabis. Según el informe la evidencia científica conclusiva o sustancial ha demostrado que los productos de cannabis son eficaces en el...

Pages